Summary of Key Points Core Viewpoint - Tianchen Medical (SH 688013) announced a share buyback program, indicating a commitment to enhancing shareholder value through capital return strategies [1]. Company Performance - As of August 31, 2025, the company has repurchased approximately 2.51 million shares, representing 3.09% of its total share capital [1]. - The highest repurchase price was 21 CNY per share, while the lowest was 11.87 CNY per share, with a total expenditure of approximately 42.5 million CNY [1]. - For the fiscal year 2024, the company's revenue composition shows that medical devices accounted for 99.99% of total revenue, with other businesses contributing only 0.01% [1]. - The current market capitalization of Tianchen Medical is 4.7 billion CNY [1].
天臣医疗：累计回购约251万股